Navigation Links
WHO, UNICEF Issue New Guidelines For Oral Rehydration Salts

The World Health Organization (WHO) and UNICEF have announced a new formula for the preparation of Oral Rehydration Salts (ORS) that is designed to minimize the occurrence of acute diarrhoeal disease.// The new formula will also help the health agencies achieve the target of reducing child mortality by two-thirds before 2015.

Diarrhea is the second leading cause of child mortality and kills nearly 2 million children each year. The new formula contains a reduced amount of glucose and sodium (245 mOsm/l compared with the previous 311 mOsm/l) so as to allow the fluids to be absorbed more quickly. This will also decrease the need for intravenous fluids and make it simpler to treat children with acute non-cholera diarrhoea without unnecessary hospitalization. ORS is the simplest way of keeping a child alive during episodes of acute diarrhea and replenishing the fast-depleting electrolytes and fluids. WHO is the only organization that has standardized the formula for ORS and keeps updating it constantly. WHO and UNICEF jointly issued the new guidelines. WHO and UNICEF will help national authorities in the adoption of these new recommendations. The organizations also said that adequate provision must be made for zinc supplements and babies should continue to be breast fed during acute episodes of diarrhea. Breastfeeding will protect against dehydration and reduce protein and calorie consumption thus combating diarrhea and malnutrition in children.
'"/>




Page: 1

Related medicine news :

1. Breastfeeding Revisited thanks to WHO and UNICEF
2. Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness
3. UNICEF To Launch A Programme For Zimbabwe Children
4. UNICEF To Help For The Betterment Of Refugee Kids in Chhattisgarh
5. UNICEF Facts & Figures About Maternal Death In India On The Eve Of Mother’s Da
6. UNICEF Ties Up With US Basketball Association To Fight AIDS
7. Asian Cricket Council and UNICEF Join Hands for Global AIDS Campaign
8. Indian Scientist to Help Reduce Infant Mortality in Africa: UNICEF
9. UNICEF Provides 1,000 ITNs to Help Combat Malaria Outbreak in Jamaica
10. UNICEF to Help Children Fight AIDS
11. Unsatisfactory Grade On Womens Health Issues
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... will become Quality Insights beginning January 1, 2017. The name change aligns ... commitment to measuring and improving health care quality. , “We are very proud ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc ... Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: ... , Results of the comparative usability study demonstrate that a dictation-based method (“NLP ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Research and Markets has announced the addition of the "Endodontic Supplies ... ... the worldwide markets for Endodontic Supplies in US$ Thousand. The report provides separate ... , Europe , Asia-Pacific , ... and forecasts are provided for the period 2015 through 2022. Also, a six-year ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: